Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DiNonA Inc.

www.dinonainc.com

Latest From DiNonA Inc.

3SBio Outlines Plans For $540m IPO Spoils

China biotech firm 3SBio, which delisted from Nasdaq in 2013, has raised HKD$4.17bn ($540 million) through an initial public offering on the Hong Kong stock exchange, which it will use mainly to expand its product portfolio and pipeline.

BioPharmaceutical China

Korea’s Corestem, Kyongbo Plan IPOs On Bullish Sentiment

With global biotech and pharma stocks in the spotlight this year, more South Korean companies are trying to benefit from the bullish market sentiment and go public. Most recently, Corestem and Kyongbo Pharm have filed IPO plans to debut on stock markets in June.

BioPharmaceutical South Korea

South Korea Launches Second Pharma Development Fund

South Korea’s Ministry of Health and Welfare is launching its second ‘Global Pharma Industry Development Fund’ worth KRW135 billion ($124 million) to help small and mid-sized local firms with cooperative technology development, deals with foreign venture firms, sales networks and production facilities in foreign countries, and global clinical trials.

BioPharmaceutical South Korea

Asia Spotlight: Hot Money Fuels China Biotech ‘Me-Different’ Ambitions

Adagene is the latest antibody firm to receive millions in financing, adding to a growing list of upcoming Chinese biotechs looking to differentiate in a largely unpenetrated yet competitive biologics market.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • DiNonA Inc.
  • Senior Management
  • Hyung-Geun Song, CEO
  • Contact Info
  • DiNonA Inc.
    Phone: 2 578 0810
    1505 15F Mapo Trapalace, Dohwa-dong
    Mapo-gu
    Seoul,
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register